As lab testing technologies, infection control policies, and reporting metrics have evolved over the years, the diagnosis of C. difficile infections has remained a vexing and often controversial topic. Recently updated clinical practice guidelines from IDSA/SHEA attempt to shed new light on a familiar debate, but some of the same challenges remain. This webinar presents expert perspectives from two different areas of clinical practice, with commentary on lab testing dilemmas, antimicrobial stewardship, LabID reporting, and the impact of the new guidelines on current practice.
Sponsored by: Cepheid
If you would like to be contacted by the sponsor for more information, please provide us with your contact information below.
